Journal of Cardiac Failure
Volume 16, Issue 9 , Pages 786-796, September 2010

Myocardial Function With Reduced Expression of the Sodium-Calcium Exchanger

  • Maria C. Jordan, MD

      Affiliations

    • Department of Physiology, David Geffen School of Medicine at UCLA, Los Angeles, CA
    • The Cardiovascular Research Laboratory, David Geffen School of Medicine at UCLA, Los Angeles, CA
    • Corresponding Author InformationReprint requests: Maria C. Jordan, MD, Department of Physiology, Room 53-231 CHS, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave., Los Angeles, CA 90095-1751. Tel: 310-206-5538; Fax: 310-206-5661.
  • ,
  • Scott A. Henderson, PhD

      Affiliations

    • Department of Physiology, David Geffen School of Medicine at UCLA, Los Angeles, CA
    • The Cardiovascular Research Laboratory, David Geffen School of Medicine at UCLA, Los Angeles, CA
  • ,
  • Tieyan Han, MD

      Affiliations

    • Department of Physiology, David Geffen School of Medicine at UCLA, Los Angeles, CA
    • The Cardiovascular Research Laboratory, David Geffen School of Medicine at UCLA, Los Angeles, CA
  • ,
  • Michael C. Fishbein, MD

      Affiliations

    • Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
  • ,
  • Kenneth D. Philipson, PhD

      Affiliations

    • Department of Physiology, David Geffen School of Medicine at UCLA, Los Angeles, CA
    • Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
    • The Cardiovascular Research Laboratory, David Geffen School of Medicine at UCLA, Los Angeles, CA
  • ,
  • Kenneth P. Roos, PhD

      Affiliations

    • Department of Physiology, David Geffen School of Medicine at UCLA, Los Angeles, CA
    • The Cardiovascular Research Laboratory, David Geffen School of Medicine at UCLA, Los Angeles, CA

Received 15 September 2009; received in revised form 4 March 2010; accepted 31 March 2010. published online 14 May 2010.

Abstract 

Background

The complete removal of the cardiac sodium-calcium exchanger (NCX1) is associated with embryonic lethality, whereas its overexpression is linked to heart failure. To determine whether or not a reduced expression of NCX1 is compatible with normal heart structure and function, we studied 2 knockout (KO) mouse models with reduced levels of NCX1: a heterozygous global KO (HG-KO) with a 50% level of NCX1 expression in all myocytes, and a ventricular-specific KO (V-KO) with NCX1 expression in only 10% to 20% of the myocytes.

Methods and Results

Both groups of mice were evaluated at baseline, after transaortic constriction (TAC), and after acute or chronic β-adrenergic stimulation. At baseline, the HG-KO mice had smaller hearts and the V-KO mice had larger hearts than their wild-type (WT) controls (P < .05). The HG-KO and their control WT mice had normal responses to TAC and β-adrenergic stimulation. However, the V-KO group was intolerant to TAC and had a significantly (P < .05) blunted response to β-adrenergic stimulation as compared with the HG-KO mice and WT controls. Unlike the HG-KO mice, the V-KO mice did not tolerate chronic isoproterenol infusion. Telemetric analysis of the electrocardiogram, body temperature, and activity revealed a normal diurnal rhythm in all groups of mice, but confirmed shorter QT intervals along with increased arrhythmias and reduced R wave to P wave amplitude ratios in the V-KO mice.

Conclusions

Though NCX1 can be reduced by half in all myocytes without significant functional alterations, it must be expressed in more than 20% of the myocytes to prevent severe remodeling and heart failure in mouse heart.

Key Words: Heart failure, hypertrophy, ventricular dysfunction, knock-out mice

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Philipson has received support from NIH HL-48509, Dr. Fishbein has received support from Piansky Family Trust and Dr. Roos has received support from Laubisch Endowment Funds.

 See page 796 for disclosure information.

PII: S1071-9164(10)00151-X

doi:10.1016/j.cardfail.2010.03.012

Journal of Cardiac Failure
Volume 16, Issue 9 , Pages 786-796, September 2010